Use of the Tesio catheter for hemodialysis in patients with end-stage renal failure: a 2-year prospective study.
BACKGROUND
The Tesio catheter system has been proposed to be a reliable source of vascular access for the dialysis patient with low rates of infection and other complications. Whether such catheters provide reliable short- and long-term access remains undetermined.


METHODS
This study prospectively examined all Tesio lines inserted over a 2-year period in patients with end-stage failure with careful recording of all catheter complications and reasons for catheter loss.


RESULTS
100 catheters were inserted in 82 patients giving a total experience of 13,749 catheter days; 74 catheters were inserted into the jugular veins, the remainder into the femoral veins; 82 insertions were covered with antibiotics. At the end of the study, 29 catheters remained in situ. Of the remaining 71 catheters, 27 catheters were removed because of fashioning of definitive access. Nine catheters were lost due to infection and 10 were lost due to non-function; 19 patients died with a functioning catheter. Episodes ofnon-function were the major complications, although catheter patency was restored in 90% of cases utilizing urokinase and warfarin. Overall 80% of femoral and 16% of jugular catheters required anticoagulation.


CONCLUSIONS
Tesio catheters inserted into the jugular or femoral veins can provide excellent access whilst awaiting definitive dialysis access. They are well-tolerated with a low complication rate compared to standard temporary central venous catheters. Non-function remains a significant problem, especially in femoral catheters, which should be anticoagulated following insertion. Because of our results we suggest that these catheters be used as part of the co-ordinated approach to the management of vascular access in end-stage renal failure patients without definitive access.
Webb
A
A
St. Lukes Hospital, Bradford, UK. alan.webb@bradfordhospitals.nhs.uk
Abdalla
M
M
Harden
P N
PN
Russell
G I
GI
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002408:Catheters, Indwelling / Q000009:adverse effects; D004866:Equipment Contamination; D004867:Equipment Design; D004869:Equipment Safety; D005260:Female; D005268:Femoral Vein / Q000601:surgery; D005500:Follow-Up Studies; D005548:Foreign-Body Migration / Q000150:complications; D006801:Humans; D007601:Jugular Veins / Q000601:surgery; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016459:Prosthesis-Related Infections / Q000209:etiology; D006435:Renal Dialysis / Q000295:instrumentation*; D013203:Staphylococcal Infections / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome; D006113:United Kingdom